Product image of Metoprololsuccinaat Sandoz (Metoprolol Tartrate) supplied by GNH India

Metoprololsuccinaat Sandoz

Active Ingredient:
Metoprolol Tartrate
Origin:
EU

Metoprololsuccinaat Sandoz (Metoprolol Tartrate)

Metoprolol Tartrate, the active ingredient in Metoprololsuccinaat Sandoz, is a beta blocker presented as an oral dosage form for oral use. It is employed to manage high blood pressure, chest pain, heart failure and to reduce risk after a heart attack in adult patients across the European Union market.

GNH India supplies Metoprololsuccinaat Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Manufacturer / TM Owner

Sandoz B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metoprololsuccinaat Sandoz, a selective β1‑adrenergic blocker, is indicated for several cardiovascular conditions.

  • Hypertension: lowers blood pressure by reducing heart rate and cardiac output.
  • Angina pectoris: relieves chest pain by decreasing myocardial oxygen demand.
  • Heart failure: improves survival and reduces hospitalizations by decreasing cardiac workload.
  • Post‑myocardial infarction prophylaxis: lowers risk of recurrent events through heart rate control.
  • Cardiac arrhythmias: stabilizes abnormal heart rhythms by blocking β1 receptors.

How It Works

  • Metoprolol Tartrate exerts its effect by selectively antagonizing β1‑adrenergic receptors located primarily in cardiac tissue. By blocking these receptors, it inhibits the actions of endogenous catecholamines such as norepinephrine, leading to decreased heart rate, reduced contractility, and lowered renin release, which together diminish myocardial oxygen consumption and lower systemic blood pressure.

Side Effects

Metoprololsuccinaat Sandoz may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Fatigue: feeling of tiredness.
  • Dizziness: light‑headedness on standing.
  • Gastrointestinal discomfort: nausea or abdominal upset.

Serious or Rare Side Effects

  • Severe bradycardia: markedly low heart rate.
  • Heart block: impaired cardiac conduction.
  • Bronchospasm: airway narrowing, especially in asthmatic patients.

Precautions & Warnings

When prescribing Metoprololsuccinaat Sandoz, clinicians should consider several precautionary measures to ensure safe use.

  • Assess cardiovascular status: evaluate heart rate and blood pressure before initiation.
  • Monitor renal and hepatic function: adjust dosing in impairment.
  • Caution in asthma or COPD: β‑blockade may exacerbate bronchospasm.
  • Avoid abrupt discontinuation: taper to prevent rebound hypertension.
  • Review concomitant medications: watch for additive bradycardic or hypotensive effects.
  • Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Avoid Interactions

Metoprololsuccinaat Sandoz can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Non‑selective β‑blockers: combined use may cause excessive bradycardia.
  • Calcium channel blockers (verapamil, diltiazem): increase risk of heart block and hypotension.
  • Antidiabetic agents: may mask hypoglycemia symptoms.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: additive blood pressure lowering.
  • Diuretics: may enhance orthostatic hypotension.
  • Antidepressants (SSRIs): potential for increased plasma levels.

Frequently Asked Questions

It is a generic formulation of metoprolol tartrate, a β1‑selective blocker indicated for hypertension, angina pectoris, chronic heart failure, post‑myocardial infarction prophylaxis, and certain cardiac arrhythmias. It helps control heart rate and lower blood pressure in adult patients.

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart, preventing norepinephrine and epinephrine from binding. This reduces heart rate, myocardial contractility, and renin release, leading to decreased cardiac workload, lower oxygen demand, and reduced systemic blood pressure.

The exact dosage regimen is determined by the prescribing clinician based on the individual’s condition, response, and tolerability. Dosing may be initiated at a low dose and titrated upward as needed, following current clinical guidelines.

Safety data are limited; the drug should only be used during pregnancy or lactation if the potential benefit justifies the potential risk to the fetus or infant. Clinicians should assess each case individually and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol tartrate is a β1‑selective blocker, offering cardiac specificity with fewer respiratory side effects compared with non‑selective agents like propranolol. Compared with atenolol, it has a shorter half‑life and may require more frequent dosing, but both share similar cardiovascular benefits.

The product should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and light. Do not store in a bathroom or near heat sources, and keep out of reach of children.

It is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious adverse events include severe bradycardia, heart block, profound hypotension, and bronchospasm, particularly in patients with underlying respiratory disease. Prompt medical attention is required if symptoms such as fainting, chest pain, or difficulty breathing occur.

Patients with known hypersensitivity to metoprolol or any excipients, those with severe bradycardia, second‑ or third‑degree AV block without a pacemaker, decompensated heart failure, or uncontrolled asthma should avoid this medication unless a specialist determines it is essential.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metoprolol Tartrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT